Trial record 53 of 109 for:    fibromyalgia | Open Studies | Interventional Studies

The Effect of Tai Chi in Treating Fibromyalgia

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by Chengdu PLA General Hospital
Sponsor:
Information provided by (Responsible Party):
Yang Min, Chengdu PLA General Hospital
ClinicalTrials.gov Identifier:
NCT02257034
First received: October 2, 2014
Last updated: October 8, 2014
Last verified: October 2014
  Purpose

To evaluate the effect of Tai chi on Fibromyalgia


Condition Intervention
Fibromyalgia
Other: Taichi
Other: Dance

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Supportive Care

Resource links provided by NLM:


Further study details as provided by Chengdu PLA General Hospital:

Primary Outcome Measures:
  • Fibromyalgia Impact Questionnaire (FIQ) [ Time Frame: up to 48 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: August 2014
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Taichi
patients exercise with Tai chi
Other: Taichi
Sham Comparator: Control
patients under exercise of dance
Other: Dance

  Eligibility

Ages Eligible for Study:   40 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 40 years of age or older
  • meeting the classification of FM per the 1990 ACR criteria
  • approval by a healthcare provider for participation

Exclusion Criteria:

  • had practiced Tai chi within the past 6 months
  • had exercised >30 min three times weekly for past 3 months
  • could not independently ambulate without assistive devices
  • had BPI pain severity or interference scores less than 5
  • had planned elective surgery during study period
  • were actively involved in health-related litigation
  • were unwilling to keep all treatments/medications steady throughout the study period
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02257034

Contacts
Contact: Min Yang, Ph.D translie@live.cn

Locations
China, Sichuan
General Hospital of Chengdu Military Area Command PLA Recruiting
Chengdu, Sichuan, China, 610083
Contact: Min Yang, Ph.D       translie@live.cn   
Sponsors and Collaborators
Chengdu PLA General Hospital
  More Information

No publications provided

Responsible Party: Yang Min, Ph.D, Chengdu PLA General Hospital
ClinicalTrials.gov Identifier: NCT02257034     History of Changes
Other Study ID Numbers: TC20140601
Study First Received: October 2, 2014
Last Updated: October 8, 2014
Health Authority: China: State Administration of Traditional Chinese Medicine

Additional relevant MeSH terms:
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Nervous System Diseases
Neuromuscular Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on October 21, 2014